She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

Free Guest Editorial

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

Free

In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater

Scaling excellence: How City of Hope is transforming cancer care delivery

Free In the Archives

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

Cancer Policy

Congress passes Trump’s megabill featuring historically steep Medicaid cuts

Publications based on NIH-funded science must be made free immediately, HHS decrees

NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

“Forward funding” NIH budget plan would make competing for grants much harder

Clinical Roundup

More than half of cancer centers see AI as answer to operational challenges, report shows

Scientists uncover new approach for targeting aggressive breast cancer

Study findings expand donor pool for blood cancers

Rare pancreatic cancer shows strong response to immunotherapy

Scientists wipe out aggressive brain cancer tumors by targeting cellular “motors”

NCCN announces virtual tool for navigating guidelines

In The Clinic

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Trials & Tribulations

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Trials & Tribulations

Optimizing dosing of expensive and toxic oncology drugs: Making America healthier

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Free

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Latest Issue

Read the latest issue

DOWNLOAD THE PDF

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Jul 2025

2025 Best of ASCO Minneapolis

Sep 2025

NCCN Oncology Policy Summit: The Evolving Artificial Intelligence Landscape in Cancer Care

Data Jamboree: Enhancing Childhood Cancer Data Sharing and Utility

Third Annual Data Sharing Symposium: How Data Advances the Impact of Cancer Research

Oct 2025

NCCN 2025 Annual Congress: Hematologic Malignancies™️

View All Events

Conversations with The Cancer Letter

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Contributors

Nataliya Kovalchuk, PhD

Building cancer care resilience through international observerships: Lessons from Ukraine

Donald L. "Skip" Trump, MD

Federal funding cutbacks undermine advances in cancer research and treatment
What would Richard Nixon and Ted Kennedy think?

Linda Malkas, PhD

From “undruggable” target to clinical potential: The journey of AOH1996

City of Hope

Insights from ASCO 2025: Real-world evidence drives clinical decision-making

Trending Stories

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”
How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures
In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater

Recent Issues

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.